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Introduction
Surveillance for S. aureus (SA) nasal carriage followed
by decolonization is a validated strategy to reduce infec-
tions and mortality in hemodialysis (HD) patients. This
practice is not widespread in Belgian HD units. The cur-
rent prevalence of methicillin sensitive SA (MSSA) and
methicillin resistant SA (MRSA) carriers in our HD
population is unknown.
Objectives
To evaluate the feasibility of routine surveillance and to
assess SA prevalence, a point–prevalence survey measur-
ing the colonization rate of HD patients was organised.
Methods
Screening of all HD patients was performed in January,
June and November 2014. Home HD (n=1) and perito-
neal dialysis (n=5) patients were excluded. Separate
swabs (ESwab, Copan, Italy) were taken from anterior
nares, wounds and the insertion site of the dialysis
catheter. For MSSA detection, swabs were inoculated
directly on chromogenic SA plates (SaSelectTM medium,
Bio–Rad Laboratories, Belgium). MRSA was isolated on
chromogenic MRSA plates (BDTM BBL CHROMagar
MRSAII, Becton-Dickinson, Belgium) after overnight
enrichment in tryptic soy broth of 100µL ESwab Amies
medium. Suspected colonies were identified by gram
stain and matrix–assisted laser desorption/ionization
time–of–flight mass–spectrometry. MRSA confirmation
was obtained by mecA gene and nuc gene polymerase
chain reaction.
Results
154 patients (mean age 70 years, range 27-95 years)
from 3 HD units were screened: 1 in-hospital unit
(n=107), 2 outpatient centres (n=47). Mean dialysis time
was 4.2 years. 14% of patients were in residential care.
SA colonization rate was stable from January to Novem-
ber (26.3%). MRSA prevalence was 1.3% in January/June
and 2.8% in November. Outpatient centres showed simi-
lar MSSA prevalence (33% and 28%) to the in-hospital
unit (17%). 13 patients (9.2%) were persistent MSSA
carriers, 8 of them carrying a central line (5.6%). None
of the catheter insertion site swabs demonstrated SA.
Conclusion
Nasal MSSA prevalence in HD patients equals the general
population prevalence (29%–32%), MRSA colonization
rate (1.3%–2.8%) is low compared to the total in-hospital
at-risk population (4%). Routine surveillance 3 times a
year is achievable and should include MSSA and MRSA
screening in all HD patients. New patients should be
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